Huntsman implements mass balance concept at Switzerland site

Huntsman implements mass balance concept at Switzerland site

MOSCOW (MRC) -- Huntsman Corporation announced its production site in Monthey, Switzerland has implemented a mass balance concept and achieved REDcert2 certification, said the company.

The certification covers the production of epoxy resins products used in a variety of consumer and industrial markets.

Mass balance refers to the mixing of fossil fuels and renewable or recycled raw materials into existing systems and production processes, while rigorously tracking their quantities and translating them into mass balance units, which are digitally attributed to specific products. A third party then certifies and confirms the recycled or renewable content of final products. Mass balance simultaneously empowers customers to reach their sustainability targets while reducing our own environmental footprint.

“We have chosen to implement the Mass Balance Concept to reduce the environmental impact of the products and solutions we provide to our customers,” said Philippe Christou, Head of Environmental & Technology Intelligence for Huntsman’s Advanced Materials division. “We assist our clients in achieving their goals through the option to intentionally select a product with a carbon footprint that is substantially lower than the average of the global market. This concept enables customers to save a significant proportion of CO2 emissions without compromising on performance, while avoiding costly re-qualifications."

The Monthey site is the first Huntsman production facility to receive REDcert2 certification.

We remind, Huntsman completed the USD593m sale of its Textile Effects division to Archroma, a company owned by the private-equity firm SK Capital Partners. Archroma was set up by SK Capital Partners in 2013 after acquiring the textile chemicals, paper specialties and emulsions businesses from Swiss producer Clariant in 2013. It has about 3,000 employees in 25 facilities globally.

Solvay to supply technology license for hydrogen peroxide mega-plant in China

Solvay to supply technology license for hydrogen peroxide mega-plant in China

MOSCOW (MRC) -- Solvay, a global market leader in specialty chemicals, has signed a license agreement with Guangxi Chlor-Alkali Chemical (GHCAC) which will enable the Chinese partner to build and operate a hydrogen peroxide megaplant at Qinzhou (Guangxi Zhuang Autonomous Region) designed to support its 300 kilotons propylene oxide (PO) production and other units on site, said the company.

Under this license, Solvay will provide its proprietary hydrogen peroxide mega-scale, high productivity process technology to GHCAC, including a dedicated process design package, operating expertise, and a range of services to ensure the optimized and reliable production of the new megaplant. In addition, the company will also supply GHCAC with proprietary 2-amylanthraquinone (AQ), the key chemical contributing to the high productivity and environmentally friendly chemical processes of Solvay’s megaplant technology.

It has been further agreed that Solvay will have a hydrogen peroxide offtake after the megaplant starts up. This will support the strategic growth of Solvay’s hydrogen peroxide business in China, in particular in the southern area.

“We are very pleased that GHCAC has chosen our advanced hydrogen peroxide technology for this important megaplant project in Qinzhou,” says Peter Browning, President of Solvay’s Peroxides global business unit.” This will allow the customer to meet market needs with a process design package backed by more than 50 years of experience, which provides an energy efficient and cost competitive solution with an excellent safety track record."

Weimin Zhang, General Manager of Shanghai Chlor-Alkali Chemical, commented: “We are honored to work with Solvay in this ambitious venture, which will enable us to run the new hydrogen peroxide megaplant at lower energy consumption and less CO2 emissions than competitors. Next to the proven safety, reliability and cost effectiveness of Solvay’s high-productivity hydrogen peroxide technology, its sustainability benefits were instrumental to deploying it at our Qinzhou site."

The propylene oxide is a versatile chemical intermediate for a wide range of materials in many industrial and commercial market segments, including polyurethanes, propylene glycol ethers and propoxylated organic specialty compounds.

We remind, Solvay announces the completion of the sale of its 50% stake in the RusVinyl joint venture to its joint venture partner Sibur. At the time of closing, Solvay received €433 million in cash proceeds in Belgium which will be reported in the first quarter as cash flow from investing activities (Consolidated statement of cash flows). A capital loss of EUR174 million will be recognized in the first quarter of 2023, mainly reflecting the crystallization of historic currency translation balances.

Stepan’s Q1 profit decreased

MOSCOW (MRC) -- Stepan’s Q1 operating income fell nearly 67% year on year to USD21m as sales volumes in the surfactants and polymers segments fell amid softening demand, said the company.

Also hurting results were delays in the startup of new low 1,4 dioxane production assets and continued customer and channel destocking, the company said.

Surfactant operating income fell to USD27.1m, from USD53.8m in Q1 2022, primarily due to a 13% decline in global sales volume. Polymer operating income was USD10.0m, down from USD14.1m in Q1 2022, primarily due to an 18% decline in global sales volume, including a 19% volume decline in rigid polyols and lower demand in the specialty polyols and phthalic anhydride businesses.

“Looking forward, we believe second quarter volumes will remain depressed as markets continue to reconcile forward demand with inventory levels throughout the channel,” said CEO Scott Behrens.

“We expect second half year over year volume growth driven by modest recovery in demand for rigid polyols, growth in surfactant volumes associated with new contracted business, and a low comparable base," he said.

We remind, Stepan Company on 16 Feb 2023 reported that on 15 Feb 2023, the board of directors of Stepan Company declared a quarterly cash dividend on the Company's common stock of USD0.365/share. The dividend is payable on 15 Mar 2023, to common stockholders of record on 3 Mar 2023. The Company increased its quarterly cash dividend in 4Q 2022 by USD0.030/share, marking the 55th consecutive year that the Company has increased its cash dividend to stockholders.

China’s Kingfa to start up PPSU/PES project in June 2024

China’s Kingfa to start up PPSU/PES project in June 2024

MOSCOW (MRC) -- China’s Kingfa Science & Technology is planning to start up its 6,000 tonne/year polyphenylene sulfone/polyether sulfone (PPSU/PES) project at Zhuhai in Guangdong province in June 2024, the company said in a statement.

PPSU and PES are special engineering plastics with good resistance to heat and oxidation. Their key applications include electrical equipment, auto and medical industries.

Meanwhile, the company’s 15,000 tonne/year liquid crystal polymer (LCP) plant is expected to come on stream in December 2024.

Its 800,000 tonne/year polypropylene (PP) project at Ningbo is scheduled to complete construction in June this year, according to the statement.

We remind, China’s Kingfa Science & Technology will step up investments in the recycling business with a target to expand its production capacity of recycled plastics to 1m tonnes/year by 2025 from 400,000 tonnes/year in 2021. The company will add 400,000 tonnes/year of capacity to existing sites in China and another 200,000 tonnes/year with grassroot projects in Europe and southeast Asia, according to Willis Guan, vice president of Sales and Marketing.

LANXESS expands Lewatit range

LANXESS expands Lewatit range

MOSCOW (MRC) -- Specialty chemicals company LANXESS has grouped together 16 new ion exchange resins and absorbents for the pharmaceutical and bioprocessing industries under its trusted umbrella brand Lewatit, said the company.

They are used in various pharmaceutical and bioprocessing applications to separate and purify biomolecules. Applications of these end products range from food and animal feeds to active pharmaceutical ingredients (APIs) that are used in medicinal products.

“Typically, our products support the separation of biomolecules from complex biomass mixtures and play a key role in their further purification or stabilization,” explained Dr. Jenny Boettger, Technical Marketing Manager in the Liquid Purification Technologies (LPT) business unit at LANXESS. “As one of the leading manufacturers of ion exchange resins, we are hoping that this innovative product range will attract new customers from the pharmaceutical and bioprocessing industries and further strengthen our market position,” added the chemist.

The production of biomolecules derived from natural extracts and biological fermentation processes is strongly supported by a wide range of Lewatit ion exchange and adsorber resins. This resin technology opens up a variety of separation and purification options for all kinds of operation scales. The new types are specifically designed to be used in downstream processing for production of various biomolecules, including products from animal- and plant-sourced natural extracts. All resins are based on hydrophobic (polystyrene-divinylbenzene) or medium hydrophilic (polyacrylic) polymers. They were specifically developed to meet the high demands in industries such as biotechnology, pharmaceuticals, biopharmaceuticals, nutraceuticals, and food production in order to detoxify, convert, decolorize, or demineralize the respective molecules more easily.

Through ion exchange or adsorption processes, biomolecules such as peptides, antibiotics, vitamins, amino acids, and polysaccharides can be separated and purified more effectively. All these biomolecules are indispensable in today’s world. Antibiotics are essential for the treatment of bacterial infectious diseases. The intake of vitamins and numerous amino acids and proteins supports vital functions of the body. Diverse polysaccharides are found in part in everyday use. In the form of heparin and structure-like polysaccharides, for example, they are used to prevent venous thrombosis. In cosmetics, hyaluronic acid acts as a humectant due to its high water-binding capacity.

We remind, Advent and LANXESS announced the envisaged establishment of an Advent controlled, leading global engineering materials joint venture company with sales of around EUR 3 billion, combining the DSM Engineering Materials business with LANXESS’ High Performance Materials business.